Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
161 hedge funds and large institutions have $1.16B invested in Avid Bioservices, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 66 increasing their positions, 51 reducing their positions, and 21 closing their positions.
3,642% more call options, than puts
Call options by funds: $4.04M | Put options by funds: $108K
29% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 51
6% less funds holding
Funds holding: 172 → 161 (-11)
14% less capital invested
Capital invested by funds: $1.35B → $1.16B (-$191M)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
48% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$15.5M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$7.43M |
| 3 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$6.7M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$5.87M |
| 5 |
Jennison Associates
New York
|
+$5.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$13.1M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$11.3M |
| 3 |
SIC
Schwartz Investment Counsel
Plymouth,
Michigan
|
-$6.16M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
-$6.09M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$5.34M |
CDMO Hedge Fund Activity: Q3 2021 in Review
161 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2021, worth a combined $1.16B — down 14% from $1.35B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of CDMO and 11 opened new positions — a net loss of 10 holders — while 51 trimmed existing stakes and 66 added.
The largest buyer was State Street, adding an estimated $15.5M. The largest seller was Goldman Sachs, cutting an estimated $13.1M.
- 161 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2021, down from 172 in Q2 2021.
- Funds reported $1.16B of Avid Bioservices, Inc. Common Stock stock for Q3 2021, down 14% quarter-over-quarter.
- 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2021 and 21 closed out, a net change of -10 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2021 was State Street, an estimated $15.5M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2021 was Goldman Sachs, an estimated $13.1M sold.
Based on aggregated 13F filings for Q3 2021.